Cargando…
Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor
Rhabdoid tumor (RT) is a pediatric cancer characterized by the inactivation of SMARCB1, a subunit of the SWI/SNF chromatin remodeling complex. Although this deletion is the known oncogenic driver, there are limited effective therapeutic options for these patients. Here we use unbiased screening of c...
Autores principales: | Chasse, Maggie H, Johnson, Benjamin K, Boguslawski, Elissa A, Sorensen, Katie M, Rosien, Jessica E, Kang, Min H, Reynolds, C Patrick, Heo, Lyong, Madaj, Zachary B, Beddows, Ian, Foxa, Gabrielle E, Kitchen‐Goosen, Susan M, Williams, Bart O, Triche, Timothy J, Grohar, Patrick J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863405/ https://www.ncbi.nlm.nih.gov/pubmed/33332735 http://dx.doi.org/10.15252/emmm.202012640 |
Ejemplares similares
-
Desmoplastic small round cell tumor is dependent on the EWS-WT1 transcription factor
por: Gedminas, Jenna M., et al.
Publicado: (2020) -
(18)F-FLT Positron Emission Tomography (PET) is a Pharmacodynamic Marker for EWS-FLI1 Activity and Ewing Sarcoma
por: Osgood, Christy L., et al.
Publicado: (2016) -
A trial of mithramycin in the treatment of advanced malignant disease.
por: Sewell, I. A., et al.
Publicado: (1966) -
Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity
por: Scott, Daniel, et al.
Publicado: (2011) -
Mithramycin interacts with core histones and modulates epigenetic modifications
por: Banerjee, Amrita, et al.
Publicado: (2013)